(USD) | Dec 2023 | Q/Q |
---|---|---|
Revenue | 211.6MM | -4% |
Gross Profit | 96.6MM | -5% |
Cost Of Revenue | 115MM | -4% |
Operating Income | 21.7MM | -28% |
Operating Expenses | 74.9MM | +5% |
Net Income | 12.5MM | -41% |
R&D | 23.5MM | +6% |
G&A | 41.7MM | +5% |
Amortization | 5.1MM | -1% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Novanta Inc. (NASDAQ:NOVT) Q4 2023 Earnings Call Transcript February 28, 2024 Novanta Inc. reports earnings inline with expectations. Reported EPS is $0.63 EPS, expectations were $0.63. Novanta Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome everyone to the […]
On February 29, 2024, Robert Buckley, the Chief Financial Officer of Novanta Inc (NASDAQ:NOVT), sold 3,000 shares of the company.
Novanta ( NASDAQ:NOVT ) Full Year 2023 Results Key Financial Results Revenue: US$881.7m (up 2.4% from FY 2022). Net...
Q4 2023 Novanta Inc Earnings Call
Full Year Revenue Climbs to $882 Million with Adjusted EBITDA Reaching $196 Million
Novanta (NOVT) delivered earnings and revenue surprises of 0% and 0.70%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
BEDFORD, Mass., February 28, 2024--Novanta Inc. (Nasdaq: NOVT) ("Novanta" or the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the fourth quarter and full year 2023.
Novanta's (NASDAQ:NOVT) stock is up by a considerable 24% over the past three months. Given the company's impressive...
On February 7, 2024, Robert Buckley, the Chief Financial Officer of Novanta Inc (NASDAQ:NOVT), sold 1,500 shares of the company's stock, according to a recent SEC Filing.
BEDFORD, Mass., January 29, 2024--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its fourth quarter and full year 2023 results on Wednesday, February 28, 2024.